Gennex Laboratories (BOM:531739) FFO


BOM:531739 Gennex Laboratories Ltd BOM:531739
84 GF Score
Price ₹10.03
GF Value ₹15.45
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Gennex Laboratories FFO?

FFO (Funds from operations) only applies to REITs.

BOM:531739
84GF Score
Gennex Laboratories Ltd BOM:531739
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Gennex Laboratories (BOM:531739) Overvalued in 2026?

Based on GuruFocus' analysis, Gennex Laboratories stock appears to be undervalued. The current stock price of ₹10.03 is trading 35.1% below its estimated GF Value™ of ₹15.45. GuruFocus considers Gennex Laboratories to be Possible Value Trap.

Key valuation signals for BOM:531739:

  • FFO:
  • GF Value™: ₹15.45 vs. price of ₹10.03 (35.1% below fair value)
  • GF Score™: 84/100 with 7 warning signs

No single metric tells the full story. See the BOM:531739 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Gennex Laboratories Business Description

Address Akash Ganga, Plot No. 144, 4th Floor, Srinagar Colony, Hyderabad, TG, IND, 500 073
Gennex Laboratories Ltd is engaged in the manufacturing of bulk drugs, and intermediates, Biotech Products. Geographically, the group has a business presence in Bangladesh, Egypt, Germany, Guatemala, Iran, Israel and other countries. Its products include Guaifenesin, Methocarbamol, Fluconazole and Phenazopyridine, among others.
84GF Score

Get the complete analysis for BOM:531739

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹10.03
Price
₹15.45
GF Value